Jianzhong Xi

机构：King University, Peking University · ORCID：0000-0003-3015-8418

发表论文 172 篇 · 总被引 9758 次 · h-index 42

代表论文

• Multimodal targeting chimeras enable integrated immunotherapy leveraging tumor-immune microenvironment (2024 · Cell · 被引 64)
• Computational prediction and experimental validation identify functionally conserved lncRNAs from zebrafish to human (2024 · Nature Genetics · 被引 58)
• Rational design of a ‘two-in-one’ immunogen DAM drives potent immune response against mpox virus (2024 · Nature Immunology · 被引 54)
• Patient-derived tumor-like cell clusters for personalized chemo- and immunotherapies in non-small cell lung cancer (2024 · Cell stem cell · 被引 46)
• B7H3-targeting chimeric antigen receptor modification enhances antitumor effect of Vγ9Vδ2 T cells in glioblastoma (2023 · Journal of Translational Medicine · 被引 20)
• Carvedilol sensitizes chemotherapy by targeting STING to boost anti-tumor immunity (2025 · Cell Reports · 被引 10)